Regulating the Hyperdopaminergic Substrate in Restless Legs Syndrome With Augmentation: An Open-label Study on the Safety and Efficacy of Aripiprazole.
- DOI
- 10.1097/wnf.0000000000000707
- Published
- 2026 Sep 23
- Container
- Clinical neuropharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/wnf.0000000000000707,
title = {Regulating the Hyperdopaminergic Substrate in Restless Legs Syndrome With Augmentation: An Open-label Study on the Safety and Efficacy of Aripiprazole.},
author = {Garcia-Malo C and Martín García R and Boi S},
year = {2026},
journal = {Clinical neuropharmacology},
doi = {10.1097/wnf.0000000000000707},
url = {https://doi.org/10.1097/wnf.0000000000000707}
}RIS
TY - JOUR TI - Regulating the Hyperdopaminergic Substrate in Restless Legs Syndrome With Augmentation: An Open-label Study on the Safety and Efficacy of Aripiprazole. AU - Garcia-Malo C AU - Martín García R AU - Boi S PY - 2026 JO - Clinical neuropharmacology DO - 10.1097/wnf.0000000000000707 UR - https://doi.org/10.1097/wnf.0000000000000707 ER -
APA
C, G., R, M. G., & S, B. (2026). Regulating the Hyperdopaminergic Substrate in Restless Legs Syndrome With Augmentation: An Open-label Study on the Safety and Efficacy of Aripiprazole.. Clinical neuropharmacology. https://doi.org/10.1097/wnf.0000000000000707
Source records
- pubmed · retrieved 2026-09-27T00:06:06.331Z